Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
Blood
; 130(19): 2055-2063, 2017 11 09.
Article
in En
| MEDLINE
| ID: mdl-28912376
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purpura, Thrombotic Thrombocytopenic
/
ADAMTS13 Protein
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Blood
Year:
2017
Document type:
Article
Affiliation country:
United kingdom